2 recruiting. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Recruiting 2 |
Follow cGVHD: new trials by email Literature Review of cGVHD trials Research Report on cGVHD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study Evaluating the Safety and Efficacy of GT729 Universal Cell Injection in the Treatment of Refractory or Relapsed Chronic Graft-versus-host Disease (cGVHD) GT729 Injection - cGVHD | Early Phase 1 | Recruiting | Grit Biotechnology | 36 | 2025-12-18 | 2026-04-14 |
| Treatment of Refractory cGVHD by Donor-derived Treg Cell Injection Combined With Recombinant Human Interleukin-2 Donor-derived Treg cell injection combined with interleukin 2 - cGVHD | Early Phase 1 | Recruiting | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 18 | 2025-06-14 | 2025-09-30 |
Bronchiolitis Obliterans Syndrome (1)
Bronchial Diseases (1) · Bronchiolitis (1) · Bronchiolitis Obliterans (1) · Bronchitis (1) · Graft vs Host Disease (1) · Immune System Diseases (1) · Lung Diseases (1) · Lung Diseases, Obstructive (1) · Organizing Pneumonia (1) · Respiratory Tract Diseases (1)
Interleukin-2 (1)
Grit Biotechnology (1) · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1)
China (2)